Scientific Advisory Board

 

  • Ola Engkvist, Astra-Zeneca, Sweden (Image based drug screening and commercialization)
  • Peter Friedl, Raboud University, Nijmegen, The Netherlands/MD Anderson, Houston, USA (Cell migration and advanced microscopy)
  • Wolfgang Huber, EMBL, Heidelberg, Germany (Statistics, Bioinformatics and Modeling)
  • Xiaowei Zhuang, Harvard University, Boston, USA (Quantitative and highly multiplex imaging)